Sign in with GoogleBexxar
What is Bexxar?
Tositumomab was a drug that was approved for the treatment of relapsed or chemotherapy/rituxan-refractory Non-Hodgkin lymphoma in 2003. It was sold in the U.S. and Canada under the trade name Bexxar. Sale of the drug was discontinued and marketing approval was withdrawn in February 2014 due to the decline in usage (fewer than 75 patients in 2012) and the existence of other similar drugs.
This drug combination was developed by Corixa which was purchased by GlaxoSmithKline) in 2005.
Questions and answers on "Bexxar"
hi doctor ,my sister is suffering from non hodgkin lymphoma n undergone 8 cycles of chop n 3 cycles of mine n then 25 days of radiation therapy...
MD you should have restaging of cancer by PET-CT Scan.if disease have progressed than 3rd line of chemotherapy(DHAP/ESHAP) can be started . if there...
My father was diagnosed with lymphoma a year ago. Tumor celll expressed CD20 and CD 5 and are negative for CD 3 CD10 and CD23 and cyclin D1. he was...
MD Hello,
Hope your Dad is doing well.
I am a Nuclear Medicine Physician. In case of relapsed disease of Non-Hodgkin Lymphoma after second and third...